The US FDA is helping sponsors get a jump on pediatric cancer study requirements that take effect in August 2020 and is close to issuing two new guidance documents explaining how those provisions will be implemented.
Under the RACE for Children Act provisions that were included in the FDA Reauthorization Act, applications for novel drugs and...